277 research outputs found

    Strong coupling constants of charmed and bottom mesons with light vector mesons in QCD sum rules

    Get PDF
    We estimate the strong coupling constants of charmed and bottom mesons D(s)∗, D(s)1, B(s)∗, and B(s)1 with light vector mesons ρ, ω, K∗, and φ within the framework of light-cone QCD sum rules. We take into account the contributions of two- and three-particle distribution amplitudes of light vector mesons of twist-2, -3, and -4, and determine the values of the couplings between heavy vector (axial vector) mesons and light vector mesons. These couplings can play an essential role in understanding the charmonium absorption cross section in quark-gluon plasma. Moreover, we compare our estimations to the ones predicted by other approaches

    Strong vertices of doubly heavy spin- 3/2 -spin- 1/2 baryons with light mesons in light-cone QCD sum rules

    Get PDF
    © 2021 authors. Published by the American Physical Society. Published by the American Physical Society under the terms of the "https://creativecommons.org/licenses/by/4.0/"Creative Commons Attribution 4.0 International license. Further distribution of this work must maintain attribution to the author(s) and the published article's title, journal citation, and DOI. Funded by SCOAP3.In this paper, we analyze the vertices of doubly heavy spin-3/2-spin-1/2 baryons with light mesons within the method of light-cone QCD sum rules. These vertices are parametrized in terms of one (three) coupling constant(s) for the pseudoscalar (vector) mesons. The said coupling constants are calculated for all possible transitions. The results presented here can serve as useful information in experimental as well as theoretical studies of the properties of doubly heavy baryons

    Determination of the strong vertices of doubly heavy baryons with pseudoscalar mesons in QCD

    Full text link
    The strong coupling constant of doubly heavy baryons with light pseudoscalar mesons π \pi and K K are computed within the light cone sum rules. We take into account two-particle and three-particle distribution amplitudes of the said pseudoscalar mesons. We compare our result with the one existing in the literature

    Maternal and fetal outcomes of COVID-19, SARS, and MERS: a narrative review on the current knowledge

    Get PDF
    OBJECTIVE: Coronavirus infections, including SARS. MERS and COVID-19 have significant impact on global health as well as on pregnancies. The aim of this review was to enlighten and summarize the cumulative knowledge regarding the relationship between Coronavirus outbreaks and pregnancy. MATERIALS AND METHODS: Literature search was commenced in order to analyze the maternofetal effects of Coronavirus outbreaks. RESULTS: Fever and cough are the most common presenting symptoms of COVID-19 which mostly affects pregnant women in their 3rd trimester with a maternal mortality rate of 0-77% and fetal and neonatal mortality rates of 1.2%. Fetal demise is common in critically ill pregnant. Pregnancy seems as a worsening factor for SARS and MERS epidemics and both infections affect prominently 3rd trimester pregnancies, although abortion (57%) is a significant risk for cases of early pregnancy. Clinical course of COVID-19, SARS and MERS may be rapid and worse in pregnant women than non-pregnant individuals. Cesarean section is the choice of delivery in most reported women due to mostly obstetrical reasons, although vaginal delivery seems not a worsening factor for the disease.CONCLUSIONS: COVID-19, SARS and MERS have significant detrimental effect on pregnancy. Rapid intervention, treatment, and intensive care support are essential for infected pregnant. Timely delivery is important in order to avoid intrauterine fetal death

    Current clinician perspective on non-vitamin K antagonist oral anticoagulant use in challenging clinical cases.

    Get PDF
    OBJECTIVE: The evolution of non-vitamin K antagonist anticoagulants (NOACs) has changed the horizon of stroke prevention in atrial fibrillation (SPAF). All 4 NOACs have been tested against dose-adjusted warfarin in well-designed, pivotal, phase III, randomized, controlled trials (RCTs) and were approved by regulatory authorities for an SPAF indication. However, as traditional RCTs, these trials have important weaknesses, largely related to their complex structure and patient participation, which was limited by strict inclusion and extensive exclusion criteria. In the real world, however, clinicians are often faced with complex, multimorbid patients who are underrepresented in these RCTs. This article is based on a meeting report authored by 12 scientists studying atrial fibrillation (AF) in diverse ways who discussed the management of challenging AF cases that are underrepresented in pivotal NOAC trials. METHODS: An advisory board panel was convened to confer on management strategies for challenging AF cases. The article is derived from a summary of case presentations and the collaborative discussions at the meeting. CONCLUSION: This expert consensus of cardiologists aimed to define management strategies for challenging cases with patients who underrepresented in pivotal trials using case examples from their routine practice. Although strong evidence is lacking, exploratory subgroup analysis of phase III pivotal trials partially informs the management of these patients. Clinical trials with higher external validity are needed to clarify areas of uncertainty. The lack of clear evidence about complex AF cases has pushed clinicians to manage patients based on clinical experience, including rare situations of off-label prescriptions

    A search on the Nikiforov-Uvarov formalism

    Full text link
    An alternative treatment is proposed for the calculations carried out within the frame of Nikiforov-Uvarov method, which removes a drawback in the original theory and by pass some difficulties in solving the Schrodinger equation. The present procedure is illustrated with the example of orthogonal polynomials. The relativistic extension of the formalism is discussed.Comment: 10 page

    Exponential Type Complex and non-Hermitian Potentials in PT-Symmetric Quantum Mechanics

    Get PDF
    Using the NU method [A.F.Nikiforov, V.B.Uvarov, Special Functions of Mathematical Physics, Birkhauser,Basel,1988], we investigated the real eigenvalues of the complex and/or PTPT- symmetric, non-Hermitian and the exponential type systems, such as Poschl-Teller and Morse potentials.Comment: 14 pages, Late

    Turner syndrome and associated problems in turkish children: A multicenter study

    Get PDF
    Objective: Turner syndrome (TS) is a chromosomal disorder caused by complete or partial X chromosome monosomy that manifests various clinical features depending on the karyotype and on the genetic background of affected girls. This study aimed to systematically investigate the key clinical features of TS in relationship to karyotype in a large pediatric Turkish patient population. Methods: Our retrospective study included 842 karyotype-proven TS patients aged 0-18 years who were evaluated in 35 different centers in Turkey in the years 2013-2014. Results: The most common karyotype was 45,X (50.7%), followed by 45,X/46,XX (10.8%), 46,X,i(Xq) (10.1%) and 45,X/46,X,i(Xq) (9.5%). Mean age at diagnosis was 10.2±4.4 years. The most common presenting complaints were short stature and delayed puberty. Among patients diagnosed before age one year, the ratio of karyotype 45,X was significantly higher than that of other karyotype groups. Cardiac defects (bicuspid aortic valve, coarctation of the aorta and aortic stenosi) were the most common congenital anomalies, occurring in 25% of the TS cases. This was followed by urinary system anomalies (horseshoe kidney, double collector duct system and renal rotation) detected in 16.3%. Hashimoto’s thyroiditis was found in 11.1% of patients, gastrointestinal abnormalities in 8.9%, ear nose and throat problems in 22.6%, dermatologic problems in 21.8% and osteoporosis in 15.3%. Learning difficulties and/or psychosocial problems were encountered in 39.1%. Insulin resistance and impaired fasting glucose were detected in 3.4% and 2.2%, respectively. Dyslipidemia prevalence was 11.4%. Conclusion: This comprehensive study systematically evaluated the largest group of karyotype-proven TS girls to date. The karyotype distribution, congenital anomaly and comorbidity profile closely parallel that from other countries and support the need for close medical surveillance of these complex patients throughout their lifespan. © Journal of Clinical Research in Pediatric Endocrinology
    corecore